ba0007oc27 | (1) | ICCBH2019
Kaplan Frederick
, Hsiao Edward C
, Baujat Genevieve
, Keen Richard
, De Cunto Carmen
, Di Rocco Maja
, Brown Matthew A
, Al Mukaddam Mona M
, Grogan Donna R
, Pignolo Robert J
Objective: FOP is a rare, severely disabling disease characterized by episodic flare-ups and accumulation of heterotopic ossification (HO) leading to restricted movement, physical disability, and early death. Data from two Phase 2 interventional studies and one natural history study (NHS) were used to evaluate whether palovarotene could reduce HO following an FOP flare-up.Methods: HO volume at the flare-up site was determined by CT at baseline and 12 wee...